Malignant ascites: a source of therapeutic protein against ovarian cancer?

Ribaux, Pascale; Britan, Aurore; Thumann, Gabriele; Delie, Florence; Petignat, Patrick; Cohen, Marie

Ribaux, Pascale; Britan, Aurore; Thumann, Gabriele; Delie, Florence; Petignat, Patrick; Cohen, Marie.

Afiliación

Ribaux P; Department of Pediatrics, Gynaecology and Obstetrics, Faculty of Medicine, Geneva 1206, Switzerland.
Britan A; Translational Research Center in Oncohaematology, Faculty of Medicine, Geneva 1206, Switzerland.
Thumann G; Department of Pediatrics, Gynaecology and Obstetrics, Faculty of Medicine, Geneva 1206, Switzerland.
Delie F; Experimental Ophthalmology, University of Geneva, Geneva 1205, Switzerland.
Petignat P; Department of Ophthalmology, University Hospitals of Geneva, Geneva 1205, Switzerland.
Cohen M; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva 1205, Switzerland.

Oncotarget ; 10(57): 5894-5905, 2019 Oct 15.

Article en En | MEDLINE | ID: mdl-31666922

Palabras clave

PEDF; ascites; ovarian cancer; sleeping beauty transposon; tumor development

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_ovary_cancer Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google